Back to results
US 2025/0059221 A1Published application
Stat degraders and uses thereof
AssigneeKymera Therapeutics, Inc.
InventorsNello Mainolfi, Nan Ji, Bin Yang, Yi Zhang
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds, compositions thereof, and methods of using the same.
Claims15
1-25. (canceled)
A method of treating lymphoma in a patient comprising administering to said patient a compound selected from:
- or a pharmaceutically acceptable salt thereof, or
- a pharmaceutical composition thereof.
A method of treating large granular lymphocytic (LGL) leukemia (T and NK cell), cutaneous T cell lymphoma (CTCL), or peripheral T cell lymphoma (PTCL) in a patient comprising administering to said patient a compound selected from:
- or a pharmaceutically acceptable salt thereof, or
- a pharmaceutical composition thereof.
A method of treating a solid tumor in a patient comprising administering to said patient a compound selected from:
- or a pharmaceutically acceptable salt thereof, or
- a pharmaceutical composition thereof.
Dependencies are inferred from the claim text.